Artiva Biotherapeutics (ARTV) Insider Trading & Ownership

$12.02

+0.11 (+0.92%)

(As of 09/6/2024 ET)

Stock Analysis Analyst Forecasts Chart Financials Headlines Insider Trades SEC Filings Trends

Number Of Insiders Buying (Last 12 Months): 2
Amount Of Insider Buying (Last 12 Months): $30.00 M
Number Of Insiders Selling (Last 12 Months): 0

Get ARTV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Artiva Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ARTV Insider Buying and Selling by Quarter

Ad Behind the Markets

NASDAQ to crash 50%?

During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out... Now, he's saying there are four major cracks forming in the US economy...

Click here to learn more >>>

Artiva Biotherapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
7/22/2024	Global Strategic Fund I Venbio	Major Shareholder	Buy	416,666	$12.00	$4,999,992.00
7/22/2024	Yong-Jun Huh	Director	Buy	2,083,332	$12.00	$24,999,984.00

(Data available from 1/1/2013 forward)

ARTV Insider Trading Activity - Frequently Asked Questions

Who is on Artiva Biotherapeutics's Insider Roster?: The list of insiders at Artiva Biotherapeutics includes Global Strategic Fund I Venbio, and Yong-Jun Huh. Learn more on insiders at ARTV.
Which Artiva Biotherapeutics insiders have been buying company stock?: The following insiders have purchased ARTV shares in the last 24 months: Global Strategic Fund I Venbio ($4,999,992.00), and Yong-Jun Huh ($24,999,984.00).

How much insider buying is happening at Artiva Biotherapeutics?: Insiders have purchased a total of 2,499,998 ARTV shares in the last 24 months for a total of $29,999,976.00 bought.